Evidence map›Paper›PMID 26780912›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2016

(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.

Gianpiero Manca, Eleonora Vanzi, Domenico Rubello, Francesco Giammarile, Gaia Grassetto, Ka Kit Wong, Alan C Perkins, Patrick M Colletti, Duccio Volterrani

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Application of Dynamic [Molecular imaging and biology · 2024
    Article
  4. Role ofCancers · 2024
    Review
  5. Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2023
    Article
  6. The Prognostic and Diagnostic Value of [Journal of clinical medicine · 2023
    Article
  7. Article
  8. FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  9. Article
  10. [Molecular imaging · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Journal of cancer research and clinical oncology · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Simultaneous Integrated Boost Radiotherapy in Unresectable Stage IV (M0) Head and Neck Squamous Cell Cancer Patients: Daily Clinical Practice.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Gianpiero MancaRegional Center of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy.
Eleonora VanziService of Medical Physics, University Hospital of Siena, Viale Bracci 16, Siena, 53100, Italy. eleonora.vanzi@ao-siena.toscana.it.
Domenico RubelloDepartment of Nuclear Medicine, Santa Maria della Misericordia Rovigo Hospital, Via Tre Martiri 140, 45100, Rovigo, Italy. domenico.rubello@libero.it.
Francesco GiammarileMédecine Nucléaire, Centre Hospitalier and Biophysique, Faculté Charles Mérieux, Lyon, France.
Gaia GrassettoDepartment of Nuclear Medicine, Santa Maria della Misericordia Rovigo Hospital, Via Tre Martiri 140, 45100, Rovigo, Italy.
Ka Kit WongNuclear Medicine/Radiology Department, University of Michigan Hospital, Ann Arbor, MI, USA.
Alan C PerkinsDepartment of Radiological Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Patrick M CollettiDepartment of Radiology, Southern University of California, Los Angeles, CA, USA.
Duccio VolterraniRegional Center of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITOspedale Santa Maria della Misericordia di Rovigo · ITUniversity of Nottingham · GBUniversity of Siena · ITUniversity of Southern California · USVA Ann Arbor Healthcare System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(18)F-FDG PET/CT plays a crucial role in the diagnosis and management of patients with head and neck squamous cell cancer (HNSCC). The major clinical applications of this method include diagnosing an unknown primary tumour, identifying regional lymph node involvement and distant metastases, and providing prognostic information. (18)F-FDG PET/CT is also used for precise delineation of the tumour volume for radiation therapy planning and dose painting, and for treatment response monitoring, by detecting residual or recurrent disease. Most of these applications would benefit from a quantitative approach to the disease, but the quantitative capability of (18)F-FDG PET/CT is still underused in HNSCC. Innovations in PET/CT technology promise to overcome the issues that until now have hindered the employment of dynamic procedures in clinical practice and have limited "quantification" to the evaluation of standardized uptake values (SUV), de facto a semiquantitative parameter, the limits of which are well known to the nuclear medicine community. In this paper the principles of quantitative imaging and the related technical issues are reviewed so that professionals involved in HNSCC management can reflect on the advantages of "true" quantification. A discussion is then presented on how semiquantitative information is currently used in clinical (18)F-FDG PET/CT applications in HNSCC, by discussing the improvements that could be obtained with more advanced and "personalized" quantification techniques.

Indexed as

Fluorodeoxyglucose F18Carcinoma, Squamous CellHead and Neck NeoplasmsHumansNeoplasm StagingPositron Emission Tomography Computed TomographyTreatment OutcomeFluorodeoxyglucose F1818F-FDG PET/CT quantificationHead and Neck cancer

Identifiers

PMID26780912
OpenAlexW2281851093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.